Related Experiment Video
Updated: Aug 3, 2026

08:14
MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening
Published on: October 26, 2017
[Cellular nucleic acids in serum and plasma as new diagnostic tools]
Bertram Brenig1, Ekkehard Schütz, Howard Urnovitz
1Tierärztlichen Institut, Universität Göttingen, Göttingen, BRD.
Berliner Und Munchener Tierarztliche Wochenschrift
|April 10, 2002
Summary
Diagnosing bovine spongiform encephalopathy (BSE) in live animals is crucial for veterinary and agricultural sectors. This study explores cellular nucleic acids in blood as novel biomarkers for early detection of infectious diseases like BSE.
Area of Science:
- Veterinary Medicine
- Neurodegenerative Diseases
- Prion Biology
Context:
- Current bovine spongiform encephalopathy (BSE) diagnosis relies on post-mortem examination of brain stem tissue.
- Protease-resistant prions are typically identified in the obex region of deceased animals.
- There is a critical need for in vivo diagnostic methods in veterinary medicine and agriculture.
Purpose:
- To investigate novel biomarkers for early in vivo detection of infectious diseases, specifically focusing on bovine spongiform encephalopathy.
- To explore the potential of circulating cellular nucleic acids in plasma or serum as surrogate markers.
- To move beyond traditional methods limited to post-mortem analysis of the central nervous system.
Summary:
- Bovine spongiform encephalopathy (BSE) diagnosis is currently restricted to post-mortem analysis of brain tissue.
- Developing an in vivo detection assay is paramount for veterinary and agricultural applications.
- This research proposes circulating cellular nucleic acids in blood as a new approach for detecting infectious diseases, offering a potential alternative to late-stage central nervous system markers.
Impact:
- Facilitates the development of early diagnostic tools for BSE in live animals.
- Enhances animal health surveillance and food safety measures.
- Opens new avenues for infectious disease diagnostics using circulating nucleic acids.

